• 1
    Malavazos AE, Corsi MM, Ermetici F et al. Proinflammatory cytokines and cardiac abnormalities in uncomplicated obesity: relationship with abdominal fat deposition. Nutr Metab Cardiovasc Dis 2007; 17: 294302.
  • 2
    Ziccardi P, Nappo F, Giugliano G et al. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 2002; 105: 804809.
  • 3
    Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993; 259: 8791.
  • 4
    Mohamed-Ali V, Goodrick S, Rawesh A et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 1997; 82: 41964200.
  • 5
    Kelly RA, Smith TW. Cytokines and cardiac contractile function. Circulation 1997; 95: 778781.
  • 6
    Abbatecola AM, Ferrucci L, Grella R et al. Diverse effect of inflammatory markers on insulin resistance and insulin-resistance syndrome in the elderly. J Am Geriatr Soc 2004; 52: 399404.
  • 7
    Reilly MP, Rohatgi A, McMahon K et al. Plasma cytokines, metabolic syndrome, and atherosclerosis in humans. J Investig Med 2007; 55: 2635.
  • 8
    Rutter MK, Meigs JB, Sullivan LM, D'Agostino RB Sr, Wilson, PW. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation 2004; 110: 380385.
  • 9
    Gabriely I, Ma XH, Yang XM et al. Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process? Diabetes 2002; 51: 29512958.
  • 10
    Pitombo C, Araujo EP, De Souza CT et al. Amelioration of diet-induced diabetes mellitus by removal of visceral fat. J Endocrinol 2006; 191: 699706.
  • 11
    Lemieux I, Pascot A, Prud'homme D et al. Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. Arterioscler Thromb Vasc Biol 2001; 21: 961967.
  • 12
    Pou KM, Massaro JM, Hoffmann U et al. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation 2007; 116: 12341241.
  • 13
    Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 2007; 56: 10101013.
  • 14
    Snijder MB, Visser M, Dekker JM et al. Low subcutaneous thigh fat is a risk factor for unfavourable glucose and lipid levels, independently of high abdominal fat. The Health ABC Study. Diabetologia 2005; 48: 301308.
  • 15
    Goodpaster BH, Thaete FL, Simoneau JA, Kelley DE. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes 1997; 46: 15791585.
  • 16
    Park YW, Allison DB, Heymsfield SB, Gallagher D. Larger amounts of visceral adipose tissue in Asian Americans. Obes Res 2001; 9: 381387.
  • 17
    Forouhi NG, Sattar N, McKeigue PM. Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians. Int J Obes Relat Metab Disord 2001; 25: 13271331.
  • 18
    Hill JO, Sidney S, Lewis CE, Tolan K, Scherzinger AL, Stamm ER. Racial differences in amounts of visceral adipose tissue in young adults: the CARDIA (Coronary Artery Risk Development in Young Adults) study. Am J Clin Nutr 1999; 69: 381387.
  • 19
    Stanforth PR, Jackson AS, Green JS et al. Generalized abdominal visceral fat prediction models for black and white adults aged 17–65 y: the HERITAGE Family Study. Int J Obes Relat Metab Disord 2004; 28: 925932.
  • 20
    Ainsworth BE, Haskell WL, Whitt MC et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000; 32: S498S504.
  • 21
    Beekman AT, Deeg DJ, Van Limbeek J, Braam AW, De Vries MZ, Van Tilburg W. Criterion validity of the Center for Epidemiologic Studies Depression scale (CES-D): results from a community-based sample of older subjects in The Netherlands. Psychol Med 1997; 27: 231235.
  • 22
    McDowell I, Kristjansson B, Hill GB, Hebert R. Community screening for dementia: the Mini Mental State Exam (MMSE) and Modified Mini-Mental State Exam (3MS) compared. J Clin Epidemiol 1997; 50: 377383.
  • 23
    Pahor M, Chrischilles EA, Guralnik JM et al. Drug data coding and analysis in epidemiologic studies. Eur J Epidemiol 1994; 10: 405411.
  • 24
    Saijo Y, Kiyota N, Kawasaki Y et al. Relationship between C-reactive protein and visceral adipose tissue in healthy Japanese subjects. Diabetes Obes Metab 2004; 6: 249258.
  • 25
    Piche ME, Lemieux S, Weisnagel SJ et al. Relation of high-sensitivity C-reactive protein, interleukin-6, tumor necrosis factor-alpha, and fibrinogen to abdominal adipose tissue, blood pressure, and cholesterol and triglyceride levels in healthy postmenopausal women. Am J Cardiol 2005; 96: 9297.
  • 26
    Tracy RP. Is visceral adiposity the “enemy within”? Arterioscler Thromb Vasc Biol 2001; 21: 881883.
  • 27
    Ludescher B, Najib A, Baar S et al. Gender specific correlations of adrenal gland size and body fat distribution: a whole body MRI study. Horm Metab Res 2007; 39: 515518.
  • 28
    Kanaya AM, Harris T, Goodpaster BH, Tylavsky F, Cummings SR. Adipocytokines attenuate the association between visceral adiposity and diabetes in older adults. Diabetes Care 2004; 27: 13751380.
  • 29
    Hube F, Birgel M, Lee YM, Hauner H. Expression pattern of tumour necrosis factor receptors in subcutaneous and omental human adipose tissue: role of obesity and non-insulin-dependent diabetes mellitus. Eur J Clin Invest 1999; 29: 672678.
    Direct Link: